| __timestamp | ACADIA Pharmaceuticals Inc. | BioCryst Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 51796000 |
| Thursday, January 1, 2015 | 73869000 | 72758000 |
| Friday, January 1, 2016 | 99284000 | 61008000 |
| Sunday, January 1, 2017 | 149189000 | 66962000 |
| Monday, January 1, 2018 | 187163000 | 84888000 |
| Tuesday, January 1, 2019 | 240385000 | 107068000 |
| Wednesday, January 1, 2020 | 319130000 | 122964000 |
| Friday, January 1, 2021 | 239415000 | 208808000 |
| Saturday, January 1, 2022 | 361575000 | 253297000 |
| Sunday, January 1, 2023 | 351619000 | 216566000 |
Igniting the spark of knowledge
In the competitive world of biopharmaceuticals, innovation is key to staying ahead. ACADIA Pharmaceuticals Inc. and BioCryst Pharmaceuticals, Inc. have been at the forefront of this race, investing heavily in research and development (R&D) over the past decade. From 2014 to 2023, ACADIA consistently outpaced BioCryst, with R&D expenses peaking at approximately 360 million in 2022, a staggering 42% higher than BioCryst's peak in the same year. This trend highlights ACADIA's commitment to innovation, as they have increased their R&D spending by nearly 500% since 2014. Meanwhile, BioCryst has also shown a commendable growth trajectory, doubling their R&D investment over the same period. As these companies continue to push the boundaries of medical science, their financial commitment to R&D underscores the importance of innovation in driving future breakthroughs.
R&D Spending Showdown: Eli Lilly and Company vs ACADIA Pharmaceuticals Inc.
R&D Spending Showdown: Merck & Co., Inc. vs ACADIA Pharmaceuticals Inc.
Amgen Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and ACADIA Pharmaceuticals Inc.
Research and Development Investment: argenx SE vs BioCryst Pharmaceuticals, Inc.
Ascendis Pharma A/S vs ACADIA Pharmaceuticals Inc.: Strategic Focus on R&D Spending
Grifols, S.A. vs ACADIA Pharmaceuticals Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Corcept Therapeutics Incorporated vs BioCryst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: CRISPR Therapeutics AG vs BioCryst Pharmaceuticals, Inc.
R&D Spending Showdown: ACADIA Pharmaceuticals Inc. vs Amicus Therapeutics, Inc.
Comparing Innovation Spending: Agios Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for BioCryst Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.